ISTH guidelines for antithrombotic treatment in COVID-19.
Schulman S, Sholzberg M, Spyropoulos AC, Zarychanski R, Resnick HE, Bradbury CA, Broxmeyer L, Connors JM, Falanga A, Iba T, Kaatz S, Levy JH, Middeldorp S, Minichiello T, Ramacciotti E, Samama CM, Thachil J; International Society on Thrombosis and Haemostasis.
Schulman S, et al. Among authors: samama cm.
J Thromb Haemost. 2022 Oct;20(10):2214-2225. doi: 10.1111/jth.15808. Epub 2022 Jul 29.
J Thromb Haemost. 2022.
PMID: 35906716
Free PMC article.
Among non-critically ill patients hospitalized for COVID-19, the panel gave a strong recommendation (a) for use of prophylactic dose of low molecular weight heparin or unfractionated heparin (LMWH/UFH) (COR 1); (b) for select patients in this group, use of therapeutic dose …
Among non-critically ill patients hospitalized for COVID-19, the panel gave a strong recommendation (a) for use of prophylactic dose of low …